📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: BioNovion

1.1 - Company Overview

BioNovion Logo

BioNovion

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of immune oncology antibody discovery and development focused on antibodies for the immune therapy of cancer; U.S.-based, founded in 2011 and acquired by Aduro BioTech in 2015.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to BioNovion

Lightpoint Medical Logo

Lightpoint Medical

HQ: United Kingdom Website
  • Description: Provider of intraoperative imaging technology for real-time cancer detection during surgery, including Cerenkov Luminescence Imaging (CLI) to reduce recurrence and reoperation; offers SENSEI®, a miniature gamma probe for minimally-invasive and robot-assisted procedures to detect radiation and guide surgeons.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lightpoint Medical company profile →
Pelican Therapeutics Logo

Pelican Therapeutics

HQ: United States Website
  • Description: Provider of next-generation TNF-based immunotherapy biologic agents, focused on developing and commercializing monoclonal antibody and fusion protein therapies designed to activate the immune system.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pelican Therapeutics company profile →
Carrick Therapeutics Logo

Carrick Therapeutics

HQ: Ireland Website
  • Description: Provider of cancer therapeutics targeting molecular pathways driving aggressive and resistant cancers. Pipeline includes Samuraciclib (CT7001), an oral CDK7 inhibitor in clinical development for HR+, HER2- advanced breast cancer and triple negative breast cancer, and a CDK12/13 inhibitor/Cyclin-K glue-degrader in IND enabling toxicology studies targeting genomic stability and DNA repair.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Carrick Therapeutics company profile →
DiaCarta Logo

DiaCarta

HQ: United States Website
  • Description: Provider of precision molecular diagnostics, including CE/IVD-marked KRAS detection, for cancer screening, monitoring, and therapy guidance. Offerings include RadTox for real-time cfDNA treatment response; ColoScape for colorectal screening and FIT-positive triage via plasma cfDNA changes; QClamp for sensitive ctDNA mutation detection; OptiSeq Colorectal Cancer NGS Panel for actionable mutations; Oncuria urine biomarkers; and custom mini-MRD panels.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DiaCarta company profile →
Sareum Logo

Sareum

HQ: United Kingdom Website
  • Description: Provider of targeted small molecule therapeutics for cancer and autoimmune diseases, delivering drug candidates for licensing at pre-clinical or early clinical stages. Pipeline includes SDC-1801 and SDC-1802 (TYK2/JAK1 inhibitors) and SRA737 (clinical-stage, oral, selective Chk1 inhibitor).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sareum company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for BioNovion

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to BioNovion

2.2 - Growth funds investing in similar companies to BioNovion

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for BioNovion

4.2 - Public trading comparable groups for BioNovion

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to BioNovion

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About BioNovion

What does BioNovion do?

BioNovion is a provider of immune oncology antibody discovery and development focused on antibodies for the immune therapy of cancer; U.S.-based, founded in 2011 and acquired by Aduro BioTech in 2015.

Who are BioNovion's competitors?

BioNovion's competitors and similar companies include Lightpoint Medical, Pelican Therapeutics, Carrick Therapeutics, DiaCarta, and Sareum.

Where is BioNovion headquartered?

BioNovion is headquartered in United States.

How many employees does BioNovion have?

BioNovion has 1,000 employees 🔒.

When was BioNovion founded?

BioNovion was founded in 2010 🔒.

What sector and industry vertical is BioNovion in?

BioNovion is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for BioNovion

Who are the top strategic acquirers in BioNovion's sector and industry

Top strategic M&A buyers and acquirers in BioNovion's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for BioNovion?

Top strategic M&A buyers groups and sectors for BioNovion include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in BioNovion's sector and industry vertical

Which are the top PE firms investing in BioNovion's sector and industry vertical?

Top PE firms investing in BioNovion's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in BioNovion's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in BioNovion's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in BioNovion's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to BioNovion include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in BioNovion's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for BioNovion?

The key public trading comparables and valuation benchmarks for BioNovion include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for BioNovion for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for BioNovion with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in BioNovion's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for BioNovion with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in BioNovion's' sector and industry vertical?

Access recent funding rounds and capital raises in BioNovion's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for BioNovion